Christoph Tinchon

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

Breast Oncology, Overall Survival, Medicine +7

Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies

Holger W. Auner, Christoph Tinchon, Werner Linkesch et al. · Annals of Hematology · 2003 · 178 citations

Troponin T, Anthracycline Cardiotoxicity, Hematology +5

Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry

Simon Peter Gampenrieder, Gabriel Rinnerthaler, Christoph Tinchon et al. · Breast Cancer Research · 2021 · 146 citations · Full text

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Stefan Kubicka, Richard Greil, Thierry André et al. · Annals of Oncology · 2013 · 101 citations · Full text

Gastrointestinal Oncology, Medicine, Pathology +8

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group

Lisa Pleyer, Sonja Burgstaller, Michael Girschikofsky et al. · Annals of Hematology · 2014 · 93 citations · Full text

Hematological Malignancy, Austrian Azacitidine Registry, Agmt-study Group +13